Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: May 9, 2025
Language: Английский
Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: May 9, 2025
Language: Английский
Advances in Clinical Medicine, Journal Year: 2025, Volume and Issue: 15(04), P. 1433 - 1440
Published: Jan. 1, 2025
Language: Английский
Citations
0Journal of Inflammation Research, Journal Year: 2025, Volume and Issue: Volume 18, P. 5519 - 5531
Published: April 1, 2025
This study aimed to investigate the protective effect of bergenin on myocardial ischemia/reperfusion (I/R) injury and elucidate its underlying mechanism. The in vivo model I/R was established by transient ligation left anterior descending coronary artery Sprague-Dawley rats, which were divided into sham, I/R, I/R+bergenin, I/R+bergenin+erastin (an agonist ferroptosis) groups.After established, rats underwent echocardiography assess cardiac function. Hematoxylin eosin (HE) staining Masson's trichrome performed evaluate pathological damage. Malondialdehyde (MDA), reactive oxygen species (ROS), glutathione (GSH) iron levels measured determine ferroptosis level. Western blotting used detect expression related proteins. Next, H9C2 cells subjected oxygen-glucose deprivation/reoxygenation (OGD/R) mimic vitro injury. EX527, a SIRT1 inhibitor, further explore role protection bergenin. In this part experiment, four groups: control, OGD/R, OGD/R+bergenin, OGD/R+bergenin+EX527. experiments, we found that group showed obvious damage, oxidative stress ferroptosis, while pretreatment reversed above injury, but inhibited inducer erastin. compared with OGD/R group, reduced level, mitochondrial dysfunction cells. We myocardium abrogated EX527. Moreover, activated SIRT1, increased phosphorylation AMPK level PGC-1α. Bergenin exerted modulating process during through SIRT1/AMPK/PGC-1α pathway.
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: March 21, 2025
Heart aging involves a complex interplay of genetic and environmental influences, leading to gradual deterioration cardiovascular integrity function. Age-related physiological changes, including ventricular hypertrophy, diastolic dysfunction, myocardial fibrosis, increased arterial stiffness, endothelial are influenced by key mechanisms like autophagy, inflammation, oxidative stress. This review aims explore the therapeutic potential plant-derived bioactive antioxidants in mitigating heart aging. These compounds, often rich polyphenols, flavonoids, other phytochemicals, exhibit notable antioxidant, anti-inflammatory, cardioprotective properties. substances have intricate properties, ability scavenge ROS, enhance endogenous antioxidant defenses, regulate signaling pathways, impede fibrosis inflammation-promoting processes. By focusing on molecular linked cardiac aging, produced from plants provide significant promise reduce age-related decline improve general health. Through comprehensive analysis preclinical clinical studies, this work highlights associated with promising effects antioxidants. The findings may helpful for researchers identifying specific molecules preventive heart.
Language: Английский
Citations
0Phytomedicine, Journal Year: 2025, Volume and Issue: 142, P. 156783 - 156783
Published: April 18, 2025
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: May 9, 2025
Language: Английский
Citations
0